General Information of Drug (ID: DR1095)
Drug Name
Minoxidil
Synonyms
Minodyl; Minossidile [Italian]; Minoxidilum; Minoxidilum [INN-Latin]; Minoximen; Normoxidil; Prexidil; Regaine; Rogaine; Theroxidil; Tricoxidil; U-10858; Alopexil; Alostil; Apo-Gain; Avacor and Mintop; Loniten; Lonolox; minoxidil; 2,4-Diamino-6-piperidinopyrimidine 3-oxide; 2,4-Pyrimidinediamine, 6-(1-piperidinyl)-, 3-oxide; 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide; 38304-91-5; 6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide; 6-(piperidin-1-yl)pyrimidine-2,4-diamine 3-oxide; CHEBI:6942; MFCD00063409
Indication Essential hypertension [ICD11: BA00] Approved [1]
Structure
3D MOL 2D MOL
Pharmaceutical Properties Molecular Weight 209.25 Topological Polar Surface Area 88.9
Heavy Atom Count 15 Rotatable Bond Count 1
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 3
Cross-matching ID
PubChem CID
4201
PubChem SID
855572 ; 4428325 ; 6790804 ; 7847484 ; 7980000 ; 8149432 ; 8152627 ; 10321504 ; 11111457 ; 11111458 ; 11113580 ; 11119965 ; 11120453 ; 11120941 ; 11121450 ; 11121930 ; 11147048 ; 11335335 ; 11360574 ; 11362519 ; 11363863 ; 11365081 ; 11366425 ; 11367643 ; 11368987 ; 11370309 ; 11370310 ; 11371637 ; 11373244 ; 11373724 ; 11375805 ; 11377149 ; 11461546 ; 11466048 ; 11467168 ; 11484742 ; 11485716 ; 11488869 ; 11490325 ; 11491878 ; 11494783 ; 12013813 ; 12016118 ; 14797675 ; 15121148 ; 17405347 ; 24715035 ; 26512261 ; 26611827 ; 26679549
ChEBI ID
ChEBI:6942
CAS Number
38304-91-5
TTD Drug ID
D0Y2CJ
Formula
C9H15N5O
Canonical SMILES
C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
InChI
1S/C9H15N5O/c10-7-6-8(12-9(11)14(7)15)13-4-2-1-3-5-13/h6H,1-5,10H2,(H2,11,12)
InChIKey
ZIMGGGWCDYVHOY-UHFFFAOYSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
Minoxidil Metabolite DM004443 N. A. Unclear 1 [4]
Minoxidil Metabolite DM004442 N. A. Unclear 1 [4]
Minoxidil Metabolite DM004441 N. A. Unclear 1 [4]
Minoxidil Metabolite DM004439 N. A. Unclear 1 [4]
Minoxidil Metabolite DM004437 N. A. Unclear 1 [4]
Minoxidil sulfate DM004444
4202
Unclear 1 [3]
Minoxidil Metabolite DM004438 N. A. Unclear 2 [4]
Minoxidil Metabolite DM004440 N. A. Unclear 2 [4]
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR004766 Minoxidil Minoxidil Metabolite Unclear Unclear [4]
MR004768 Minoxidil Minoxidil Metabolite Unclear Unclear [4]
MR004770 Minoxidil Minoxidil Metabolite Unclear Unclear [4]
MR004772 Minoxidil Minoxidil Metabolite Unclear Unclear [4]
MR004773 Minoxidil Minoxidil Metabolite Unclear Unclear [4]
MR004774 Minoxidil Minoxidil sulfate Unclear SULT2B1 [3]
MR004767 Minoxidil Metabolite Minoxidil Metabolite Unclear TDO2 [4]
MR004769 Minoxidil Metabolite Minoxidil Metabolite Unclear Unclear [4]
MR004771 Minoxidil Metabolite Minoxidil Metabolite Unclear Unclear [4]
⏷ Show the Full List of 9 MR(s)
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Sulfotransferase 1A1 (SULT1A1) DME0008 Homo sapiens
ST1A1_HUMAN
2.8.2.1
[2]
Sulfotransferase 2B1 (SULT2B1) DME0384 Homo sapiens
ST2B1_HUMAN
2.8.2.2
[3]
Tryptophan oxygenase (TRPO) DME0172 Homo sapiens
T23O_HUMAN
1.13.11.11
[4]
UDP-glucuronosyltransferase 1A1 (UGT1A1) DME0004 Homo sapiens
UD11_HUMAN
2.4.1.17
[5]
References
1 Minoxidil was approved by FDA. The 2020 official website of the U.S. Food and Drug Administration.
2 Sulfation of minoxidil by multiple human cytosolic sulfotransferases. Chem Biol Interact. 1998 Feb 20;109(1-3):53-67.
3 The effect of topical minoxidil treatment on follicular sulfotransferase enzymatic activity
4 Metabolism of minoxidil, a new hypotensive agent II: biotransformation following oral administration to rats, dogs, and monkeys
5 Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Drug Metab Dispos. 2004 Apr;32(4):413-23.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.